Page 2 - Metastatic castration-naive and castration-sensitive prostate cancer: CUA/CUOG

Conflicts of interest

Dr. So has been an advisory board member for Abbvie, Amgen, Astellas, Bayer, Janssen, Ferring, and TerSera; and has participated in clinical trials
supported by Astellas, Ferring, and Janssen.
Dr. Chi has received honoraria from Astellas, Bayer, Janssen, and Sanofi; and has participated in clinical trials supported by Astellas, AstraZeneca, Bayer, Eli
Lilly, Essa, Janssen, Merck, Novartis, Pfizer, Roche, and Sanofi.
Dr. Danielson has received advisory board honoraria and speaker fees from Amgen, Astellas, Bayer, and Janssen.
Dr. Fleshner has been a consultant or advisory board member for Abbvie, Amgen, Astellas, Bayer, Ferring, Hybridyne Health, Janssen, and Sanofi; and has
participated in clinical trials supported by Astellas, Bavarian Nordic, Bayer, Ferring, Janssen, Medivalion, Nucleix, Progenics Pharmaceutical, Sanofi, and
Spectracure AB.
Dr. Kapoor has been an advisory board member for BMS, Eisai, Ipsen, Merck, Novartis, Pfizer, and Roche; a speakers’ bureau member for Eisai, Ipsen,
Novartis, and Roche; and has received grants/honoraria from BMS, Eisai, Ipsen, Merck, Novartis, Pfizer, and Roche.
Dr. Niazi has received research grants and honoraria from Abbvie, Amgen, Astellas, Astra Zeneca, Bayer, Janssen, and Sanofi; and has participated in clinical
trials supported by Astellas, Ferring, Janssen, and Sanofi.
Dr. Pouliot has been an advisory board member for Amgen, Astellas, Bayer, and Janssen; has received payment from Abbott, Amgen, Astellas, Astra Zeneca,
Bayer, Ferring, Janssen, and Sanofi; has received grants from Astra Zeneca and Sanofi; and has participated in clinical trials supported by Astellas, Bayer,
Ferring, and Janssen.
Dr. Rendon has been an advisory board and speakers’ bureau member for, and has received honoraria from Abbvie, Amgen, Astellas, Astra Zeneca, Bayer,
Ferring, Jansen, and Sanofi.
Dr. Shayegan has been an advisory board member for Astellas, Bayer, and Janssen; and has received a research grant from Janssen.
Dr. Sridhar has been an advisory board member for Astellas, AstraZeneca, Bayer, Janssen, Merck, and Roche; and has participated in several pharma-
supported clinical trials. Dr. Vigneault has been an advisory board member for Abbvie, Bayer, Ferring, and Sanofi.
Dr. Saad has been an advisory board member for and has received payment/honoraria from Abbvie, Amgen, Astellas, Bayer, Janssen, and Sanofi; and has
participated in clinical trials supported by Amgen, Astellas, Bayer, Janssen, and Sanofi.